THERAPEUTIC POTENTIAL OF MicroRNAs IN PREGNANCY-RELATED DISORDERS
| dc.authorid | 0000-0003-4725-043X | tr |
| dc.contributor.author | Yurtcu, Nazan | |
| dc.date.accessioned | 2022-05-16T10:08:35Z | |
| dc.date.available | 2022-05-16T10:08:35Z | |
| dc.date.issued | 27/05/2021 | tr |
| dc.department | Tıp Fakültesi | tr |
| dc.description.abstract | miRNAs reveal irregular expressions in women with pregnancy complications (Bogdanet et al., 2021; Memtsa et al., 2019; Rana et al., 2020). Further research is required to further define an individual miRNA as a biomarker in placental disorders. Checking for disorganized placental and circulatory miRNAs is necessary in large-scale preclinical studies. According to the literature, generally, large-scale clinical trials should be planned to evaluate the clinical significance of circulating miRNAs in pregnancy-related conditions. This is important, since it will help determine their sensitivity and specificity for inclusion in clinical diagnostics and follow-up tests. Considering the multiple factors influencing the growth of pregnancy, it appears likely that a panel of various biomarkers, including genomic, transcriptomic, proteomics, and biophysical ones, combined with maternal characteristics, can be utilized to make better the health care for pregnant women in the future. | tr |
| dc.identifier.uri | https://hdl.handle.net/20.500.12418/13135 | |
| dc.language.iso | en | en_US |
| dc.relation.ispartof | HEALTH & SCIENCE | en_US |
| dc.relation.publicationcategory | Uluslararası Kitapta Bölüm | tr |
| dc.rights | info:eu-repo/semantics/openAccess | tr |
| dc.title | THERAPEUTIC POTENTIAL OF MicroRNAs IN PREGNANCY-RELATED DISORDERS | en_US |
| dc.type | Book Chapter | en_US |
